Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression
Completed · Not applicable
Conditions studied: Major Depressive Disorder
In brief
The purpose of this study is to assess the efficacy of a Deep Shaped-Field repetitive transcranial magnetic stimulation (DSF-rTMS) system in the treatment of depression.
Key facts
- Study ID
- NCT01431001
- Run by
- Cervel Neurotech, Inc.
- People needed
- 40
- Starts
- 2011-10-01
- Expected to finish
- 2013-10-01
- Last updated by the study team
- 2014-05-19
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Major depressive disorder (MDD)
- Mild to moderate level of resistance or intolerance to antidepressant treatment in the current episode.
- Will not become pregnant during study.
You may not qualify if…
- Seizure disorder.
- History of brain injury or active CNS disease.
- Metal implants on or in brain, spinal cord, ear, eye or heart.
- Current use of proconvulsant medications (e.g., bupropion).
- Other significant psychiatric disorder.
- Substance use disorder (not including caffeine or nicotine).
- 7 or more failed treatment attempts for depression in one's lifetime.
- Have failed to clinically remit to an adequate trial of ECT or TMS.
Where it is running
- Emory University — Atlanta, Georgia, United States
- Rush Medical College — Chicago, Illinois, United States
- Medical University of South Carolina — Charleston, South Carolina, United States
- Monash Alfred Psychiatry Research Centre — Melbourne, Victoria, Australia
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.